Literature DB >> 17148562

Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone.

Tatja Hirvikoski1, Anna Nordenström, Torun Lindholm, Frank Lindblad, E Martin Ritzén, Anna Wedell, Svetlana Lajic.   

Abstract

CONTEXT AND
OBJECTIVE: In Sweden, from 1985 through 1995, 40 fetuses at risk for congenital adrenal hyperplasia (CAH) were treated with dexamethasone (DEX) to prevent virilization of affected females. We report long-term effects on neuropsychological functions and scholastic performance of this controversial treatment. DESIGN AND PATIENTS: Prenatally treated children, 7 to 17 yr old, were assessed with standardized neuropsychological tests (A Developmental Neuropsychological Assessment and Wechsler Intelligence Scales for Children) and child-completed questionnaires measuring self-perceived scholastic competence (Self-Perception Profile for Children). A parent-completed questionnaire (Child Behavior Checklist/4-18 School Scale) was used to evaluate whether the treatment had any impact on the children's school performance. In addition, a child-completed questionnaire measuring social anxiety (The Social Anxiety Scale for Children-Revised) was completed by the prenatally treated children aged 8 to 17 yr (n = 21) and age- and sex-matched controls (n = 26).
RESULTS: Of 40 DEX-treated children, 26 (median age, 11 yr) participated in the study. Thirty-five sex- and age-matched healthy children were controls. There were no between-group differences concerning psychometric intelligence, measures of cerebral lateralization, memory encoding, and long-term memory. Short-term treated, CAH-unaffected children performed poorer than the control group on a test assessing verbal working memory (P = 0.003), and they rated lower on a questionnaire assessing self-perception of scholastic competence (P = 0.003). This group also showed increased self-rated social anxiety assessed by The Social Anxiety Scale for Children-Revised (P = 0.026). Prenatally treated, CAH-affected children performed poorer than controls on tests measuring verbal processing speed, although this difference disappeared when controlling for the child's full-scale IQ.
CONCLUSIONS: This study indicates that prenatal DEX treatment is associated with previously not described long-term effects on verbal working memory and on certain aspects of self-perception that could be related to poorer verbal working memory. These findings may thus question future DEX treatment of congenital adrenal hyperplasia. Therefore, we encourage additional retrospective studies of larger cohorts to either confirm or challenge the present findings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17148562     DOI: 10.1210/jc.2006-1340

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  51 in total

1.  Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation.

Authors:  Ranmal Aloka Samarasinghe; Roberto Di Maio; Daniela Volonte; Ferruccio Galbiati; Marcia Lewis; Guillermo Romero; Donald B DeFranco
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  Dexamethasone and neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia.

Authors:  Kevin R Krull
Journal:  Pediatr Blood Cancer       Date:  2019-12-25       Impact factor: 3.167

3.  Early dexamethasone treatment induces placental apoptosis in sheep.

Authors:  Thorsten Braun; Wenbin Meng; Hongkai Shang; Shaofu Li; Deborah M Sloboda; Loreen Ehrlich; Karolin Lange; Huaisheng Xu; Wolfgang Henrich; Joachim W Dudenhausen; Andreas Plagemann; John P Newnham; John R G Challis
Journal:  Reprod Sci       Date:  2014-07-25       Impact factor: 3.060

4.  Prenatal dexamethasone augments the neurobehavioral teratology of chlorpyrifos: significance for maternal stress and preterm labor.

Authors:  Edward D Levin; Marty Cauley; Joshua E Johnson; Ellen M Cooper; Heather M Stapleton; P Lee Ferguson; Frederic J Seidler; Theodore A Slotkin
Journal:  Neurotoxicol Teratol       Date:  2013-10-28       Impact factor: 3.763

5.  The clinical and biochemical spectrum of congenital adrenal hyperplasia secondary to 21-hydroxylase deficiency.

Authors:  Tony Huynh; Ivan McGown; David Cowley; Ohn Nyunt; Gary M Leong; Mark Harris; Andrew M Cotterill
Journal:  Clin Biochem Rev       Date:  2009-05

Review 6.  The next 150 years of congenital adrenal hyperplasia.

Authors:  Adina F Turcu; Richard J Auchus
Journal:  J Steroid Biochem Mol Biol       Date:  2015-06-03       Impact factor: 4.292

7.  Prenatal dexamethasone, as used in preterm labor, worsens the impact of postnatal chlorpyrifos exposure on serotonergic pathways.

Authors:  Theodore A Slotkin; Jennifer Card; Frederic J Seidler
Journal:  Brain Res Bull       Date:  2013-11-23       Impact factor: 4.077

Review 8.  Minireview: the impact of antenatal therapeutic synthetic glucocorticoids on the developing fetal brain.

Authors:  Melanie E Peffer; Janie Y Zhang; Leah Umfrey; Anthony C Rudine; A Paula Monaghan; Donald B DeFranco
Journal:  Mol Endocrinol       Date:  2015-03-12

9.  Experts' Opinion on the Prenatal Therapy of Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency - Guideline of DGKED in cooperation with DGGG (S1-Level, AWMF Registry No. 174/013, July 2015).

Authors:  H G Dörr; G Binder; N Reisch; U Gembruch; P G Oppelt; P Wieacker; J Kratzsch
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-12       Impact factor: 2.915

Review 10.  Congenital adrenal hyperplasia in pregnancy: approach depends on who is the 'patient'.

Authors:  Erin Keely; Janine Malcolm
Journal:  Obstet Med       Date:  2012-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.